[Federal Register Volume 68, Number 68 (Wednesday, April 9, 2003)]
[Notices]
[Page 17408]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-8582]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 29, 2002, Siegfried 
(USA) Inc., made application by renewal to the Drug Enforcement 
Administration for registration as a bulk manufacturer of the basic 
classes of controlled substance listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Codeine (9050).............................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oxycodone (9143)...........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Dextropropoxyphene, bulk (non dosage forms)  II
 (9273).
------------------------------------------------------------------------

    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than 60 days from publication.

    Dated: March 21, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-8582 Filed 4-8-03; 8:45 am]
BILLING CODE 4410-09-M